Quantcast
Home / Columnists / Berko / BERKO: Buy, hold or sell Flexion Therapeutics? (access required)

BERKO: Buy, hold or sell Flexion Therapeutics? (access required)

Dear Mr. Berko: I have bad osteoarthritis in my knee and read about a new drug called Zilretta (not out yet), which is supposed to bring lasting relief. It's made by a small biotech firm, called Flexion Therapeutics. Last March, my stockbroker told me that Flexion was going to be bought out by a French ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*

 

%d bloggers like this: